This topic takes on average 55 minutes to read.
There are a number of interactive features in this resource:
The UK has a long-standing reputation for research into medicine and advances in basic science meaning we understand diseases better than we've ever done before. Globally, pharmaceutical companies put around £140 billion a year in to researching and developing new medicines.
Once a chemical or biological molecule that might treat a disease has been identified it will be tested to see how good it is likely to be in treating that disease. Tests might use an antibody or cultured cells to look for the desired activity.
The promising compounds - often called 'leads' - are then made in small quantities and studied in the laboratory. Initially they will be tested on cell cultures - collections of living cells that respond as though they were part of an animal or human. Scientists can determine if the molecules are toxic (poisonous) and if they have any potential therapeutic effects (likely to treat the disease).
At the same time tests will be carried out by chemists and pharmacists to investigate how easily the compounds can be made, how likely they are to be absorbed when given orally (by mouth), and whether there might be other problems with the manufacture of a medicine made from these compounds.
Eventually, after several months of tests, a few molecules will be identified as being the most promising to become an effective medicine to treat a particular disease. These will be tested more rigorously, including tests on animals. These tests will look at whether the medicine is likely to be toxic when given every day for a long time, if it might cause cancer, and if it is likely to cause any damage to the foetus if given during pregnancy.
Before a new compound can be given to humans, tests have to be done to find out: